Latest in Weighted Blankets Robes
Sort by
78 items
-
Biden proposes weight loss drug coverage by Medicare, Medicaid
President Biden's proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump's ...Top stories - CBS News - 4 days ago -
Why Biden is proposing weight loss drug Medicare, Medicaid coverage
President Biden's proposal to expand Medicaid and Medicare coverage for some weight loss drugs could impact thousands of Americans. CBS News' Alexander Tin breaks down what's known about the ...Top stories - CBS News - 4 days ago -
How to help your dog lose weight and stay healthy
More than half of American dogs are overweight or obese – a condition that could shorten their lifespan. CBS News' Nikki Battiste shares the wellness journey of IAMS spokesdog Waylon and highlights ...Top stories - CBS News - 4 days ago -
WW sees more turnover at the top, but this bull still believes in the Weight Watchers parent
D.A. Davidson reckons WW is a buy as its customers need more than a prescription.Business - MarketWatch - 3 days ago -
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.Business - MarketWatch - November 5 -
Jesse 'Bam' Rodriguez continues to dare to be great as he takes out legends of the smaller weight classes
Rodriguez has already shared the ring with the likes of Juan Francisco Estrada, Srisaket Sor Rungvisai and Carlos CuadrasSports - CBS Sports - November 6 -
Bhad Bhabie reveals cancer battle, tells trolls to stop 'worst narratives' around her weight
Rapper Bhad Bhabie, hoping to silence the 'worst narratives' about her appearance, reveals she is battling cancer. 'I'm slowly gaining [weight] back,' she says.Entertainment - Los Angeles Times - November 9 -
Amgen says no concerns around weight loss drug’s bone density data after stock falls
Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.Business - CNBC - November 13 -
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.Science - The New York Times - November 14 -
Tyson v Paul - ringwalk time, weight, fight rules, undercard & how to follow
Everything you need to know about Jake Paul v Mike Tyson, including ringwalk time and undercard.Sports - Yahoo Sports - November 14 -
As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say
About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to several obesity experts.Top stories - CBS News - 5 days ago -
West Virginia ends promising subsidy program for GLP-1 weight loss drugs
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered in March.Top stories - CBS News - 4 days ago -
Biden seeks Medicare and Medicaid coverage of popular but costly weight-loss drugs for millions of Americans
Biden seeks Medicare and Medicaid coverage of popular but costly weight-loss drugs for millions of AmericansHealth - ABC News - 4 days ago -
Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would ...Business - MarketWatch - 4 days ago -
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.Business - CNBC - 4 days ago -
Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms
Amgen’s MariTide achieved up to 20% weight loss in a mid-stage trial, but analysts were expecting up to 25%.Business - MarketWatch - 3 days ago -
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by ...Health - ABC News - 3 days ago -
Doctor says Biden's weight-loss drug proposal is a "formal recognition" that obesity is an illness
The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare and Medicaid. CBS News medical contributor Dr. Celine Gounder discusses ...Top stories - CBS News - 3 days ago -
New White House rule would make weight loss drugs available for people on Medicare and Medicaid
A New White House proposal would make Medicare and Medicaid cover GLP-1 weight loss drugs for people who are obese. The move would expand affordable access to the drugs to some 7.4 million people. ...Top stories - CBS News - 3 days ago -
What to know about the Biden administration proposal to expand access to weight loss drugs
The Biden administration wants to expand access to popular weight loss drugs like Wegovy and Ozempic. The new proposal would allow millions of obese Americans covered by Medicaid and Medicare to be ...Top stories - CBS News - 3 days ago -
Who gets weight loss drugs covered by insurance? In North Carolina, being on Medicaid helps.
North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended coverage for Medicaid recipients.Top stories - NBC News - 2 days ago -
Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.Business - MarketWatch - 6 hours ago